According to study details released Friday as the U.S. considers opening vaccinations to that age group, kid-size doses of Pfizer's COVID-19 vaccine appear safe

Dr.Sunita Dube sets her goals right for empowering women with 10 point Program and Statue of Immunity Research Center Renowned Radiologist, Philanthropist, healthcare entrepreneur Dr.Sunita

India has achieved a major milestone in its war against Covid-19 as increasing vaccinations in the country crossed the 100 crore mark on Thursday. After

South Africa has started giving COVID-19 vaccinations to adolescents aged between 12 and 17 years, with a goal of inoculating at least 6 million

On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc (MRNA.O) and

A booster dose of the COVID-19 vaccine developed by Pfizer Inc (PFE.N) and German partner BioNTech SE (22UAy.DE) was 95.6% effective against the coronavirus when compared to a

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the launch of the Medtronic Open Innovation Platform (OIP) for APAC. The OIP

Children who contract a mild case of COVID-19 may not develop antibodies to the virus afterward, a study from Australia suggests. Researchers compared 57

Japan's Shionogi & Co Ltd (4507.T) said on Wednesday it started a Phase II/III clinical trial for its COVID-19 vaccine candidate.The trial for the recombinant protein-based

The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N),